Our Team
Mark Stevenson
Chairman
Mark has spent more than 30 years in life sciences in senior operating and strategic leadership roles, including Chief Operating Officer of Thermo Fisher Scientific, President and COO of Life Technologies, and President of Applied Biosystems. He was formerly a Senior Partner at Flagship Pioneering. Mark is currently a Senior Advisor at General Atlantic and serves on the boards of Ingersoll Rand (NYSE: IR), Qiagen (NYSE: QGEN), Harbinger Health, and Ultima Genomics.
Matthew Stevenson
Managing Partner
Matthew leads deal sourcing, due diligence, and financial modeling for Camillus Capital's investments across global healthcare, enabling technology, and sports & entertainment. He works closely with founders and management teams through diligence and supports the firm's ongoing portfolio evaluation and pipeline development. Matthew holds an MBA and an MSc in Data Science & Artificial Intelligence, bringing a quantitative, data-driven lens to diligence and strategy.